232 related articles for article (PubMed ID: 10360517)
21. [Congenital hyperthyroidism caused by diaplacental exchange of thyrotropin receptor antibodies].
Eyb H; Sperger H; Borkenstein M; Müller W; Passath A
Klin Padiatr; 1988; 200(1):74-7. PubMed ID: 3367614
[TBL] [Abstract][Full Text] [Related]
22. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
[TBL] [Abstract][Full Text] [Related]
23. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
24. [Transient neonatal hyperthyroidism caused by transplacental transport of pituitary TSH receptor antibodies].
Thibault H; Breton D; Brauner R
Arch Fr Pediatr; 1993; 50(7):581-3. PubMed ID: 8002722
[TBL] [Abstract][Full Text] [Related]
25. [Thyroid disease].
Ashitaka Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):855-60. PubMed ID: 1700036
[TBL] [Abstract][Full Text] [Related]
26. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
McNab T; Ginsberg J
Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
[TBL] [Abstract][Full Text] [Related]
27. Fetal and neonatal hyperthyroidism.
Zimmerman D
Thyroid; 1999 Jul; 9(7):727-33. PubMed ID: 10447021
[TBL] [Abstract][Full Text] [Related]
28. [Maternal autoimmune thyroid disease: relevance for the newborn].
Temboury Molina MC; Rivero Martín MJ; de Juan Ruiz J; Ares Segura S
Med Clin (Barc); 2015 Apr; 144(7):297-303. PubMed ID: 24486115
[TBL] [Abstract][Full Text] [Related]
29. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
30. [Pregnancy, labor and the thyroid gland].
Amino N; Tada H; Hidaka Y
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1167-74. PubMed ID: 9379094
[No Abstract] [Full Text] [Related]
31. [Neonatal hyperthyroidism in non-diagnosed Basedow's disease of the mother. Problems of diagnosis and therapy illustrated by a case history].
Krüger C; Dörr HG; Becker W; Wolf F; Harms D
Dtsch Med Wochenschr; 1994 Oct; 119(40):1346-50. PubMed ID: 7924939
[TBL] [Abstract][Full Text] [Related]
32. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
[TBL] [Abstract][Full Text] [Related]
33. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
34. On specificity of 2nd generation TSH receptor autoantibody measurements.
Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
[TBL] [Abstract][Full Text] [Related]
35. [Guidelines for measurement of TSH receptor antibodies in pregnant women. Results from an evidence based symposium organized by the European Thyroid Society].
Nygaard B; Laurberg P; Glinoer D; Grussendorf M; Orgiazzi J
Ugeskr Laeger; 1999 Nov; 161(44):6037-8. PubMed ID: 10778336
[No Abstract] [Full Text] [Related]
36. [Hypothyroidism and endocrine orbitopathy].
Wiesli P; Knierim M; Knierim C; Schmid C
Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
[TBL] [Abstract][Full Text] [Related]
37. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
38. Maternal autoimmune thyroid disease and the fetal immune system.
Svensson J; Oderup C; Akesson C; Uvebrant K; Hallengren B; Ericsson UB; Arvastsson J; Danska JS; Lantz M; Cilio CM
Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):445-50. PubMed ID: 21667438
[TBL] [Abstract][Full Text] [Related]
39. Significance of low thyroid-stimulating hormone in pregnancy.
Lazarus JH; Kaklamanou M
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):389-92. PubMed ID: 17940469
[TBL] [Abstract][Full Text] [Related]
40. [Clinical implications of occurrence of antithyroid antibodies in pregnant women and in the postpartum period].
Jurczyńska J; Zieleniewski W
Przegl Lek; 2004; 61(8):864-7. PubMed ID: 15789919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
